AAA Pharmaceutical, Inc. recalls Discount Drug Mart, Allergy Relief, Fexofenadine Hydrochloride Tablets…
The stated reason: Labeling: Incorrect or Missing Lot and/or Expiration date.
AAA Pharmaceutical, Inc. began a drug recall on February 14, 2020 whose reported distribution included Ohio. FDA
What the record shows
recalled Discount Drug Mart, Allergy Relief, Fexofenadine Hydrochloride Tablets, 180 mg /Antihistamine, Indoor/Outdoor Allergies, 24 Hour, a) 30 tablets per bo… beginning February 14, 2020, in a drug recall whose distribution included Ohio. FDA graded it Class III — use is not likely to cause adverse health consequences. Quantity affected: 3456 Bottles. The recall is listed as terminated. FDA
Context
By the numbers
- Date of record: February 14, 2020 FDA
- Recall number: D-0868-2020 FDA
- Recalls in this action: 1 FDA
- Recalling firm: AAA Pharmaceutical, Inc. FDA
- Product: Discount Drug Mart, Allergy Relief, Fexofenadine Hydrochloride Tablets, 180 mg /Antihistamine, Indoor/Outdoor… FDA
- Reason for recall: Labeling: Incorrect or Missing Lot and/or Expiration date. FDA
Assembled mechanically from the source filing and The Lantern's own record database — no AI-written prose. Every figure above appears verbatim in the cited record, which is linked on this page. FDA
Sources
The source filing
| Recall number | D-0868-2020 |
|---|---|
| Recalls in this action | 1 |
| Recalling firm | AAA Pharmaceutical, Inc. |
| Product | Discount Drug Mart, Allergy Relief, Fexofenadine Hydrochloride Tablets, 180 mg /Antihistamine, Indoor/Outdoor Allergies, 24 Hour, a) 30 tablets per bottle, NDC 53943-192-04, UPC Code 0-93351-03069-7; b) 45 tablets per bottle, NDC 53943-192-06, UPC Code 0-93351-03070-3, Distributed by: Drug Mart -Food Fair, 211 Commerce Drive, Medina, OH 44256. |
| Reason for recall | Labeling: Incorrect or Missing Lot and/or Expiration date. |
| Classification | Class III — use is not likely to cause adverse health consequences |
| Recall type | drug |
| Quantity | 3456 Bottles |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm initiated |
| Initiated | 20200214 |
| Reported | 20200311 |
| Distribution | Ohio |
| Firm location | Lumberton, NJ, United States |
Published by U.S. Food and Drug Administration (openFDA). This is the agency's public filing as The Lantern received it, shown with its fields named in plain English.